What happens when iron-deficiency anemia continues after upper endoscopy and colonoscopy do not find the source?
Evelyn’s path from hidden blood loss to capsule diagnosis, deep enteroscopy, treatment, and long-term monitoring
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
A 69-year-old retired librarian with recurrent iron-deficiency anemia and no obvious bleeding
Evelyn gradually stopped taking long walks because she became short of breath and exhausted much sooner than usual.
Blood tests showed iron-deficiency anemia. She had no heavy rectal bleeding, vomiting blood, or persistent abdominal pain.
Upper endoscopy and colonoscopy did not identify a source that explained the continuing iron loss.
Her gastroenterologist recommended capsule endoscopy because the small bowel remained largely unexamined.
I kept hearing that the scopes were normal, but my hemoglobin kept proving that something was not.
Evelyn’s bleeding was occult, meaning she did not see blood in the stool.
Her first symptoms came from anemia: reduced stamina, dizziness when standing, palpitations, and difficulty concentrating.
Iron replacement improved the laboratory values temporarily, but the deficiency returned after treatment stopped.
That recurrence changed the question from how to replace iron to why she kept losing it.
The diagnosis mattered because it validated the anemia and explained why earlier procedures had been unrevealing.
Evelyn watched a few capsule images showing flat red vascular spots in the small bowel.
She expected one lesion that could be permanently removed, but the study showed several angioectasias.
The specialist explained that treatment would target lesions most likely to be bleeding rather than attempt to destroy every visible vessel.
She also learned that recurrence would be measured through hemoglobin, iron, symptoms, transfusions, and future overt bleeding.
Evelyn accepted a plan designed to control the burden of disease rather than promise a one-time cure.
The evaluation became useful when each step answered a specific remaining question.
Ferritin and iron studies supported chronic blood loss rather than isolated fatigue.
EGD and colonoscopy quality, preparation, reach, and findings were reviewed.
Capsule endoscopy identified multiple angioectasias with bleeding potential.
Deep enteroscopy targeted lesions while iron and laboratory monitoring measured benefit.
Capsule endoscopy and device-assisted enteroscopy can identify and treat small-bowel vascular lesions that routine EGD and colonoscopy cannot reach.
The pathway moved from unexplained anemia to small-bowel visualization, targeted therapy, and objective follow-up.
Low hemoglobin, ferritin, and iron saturation establish ongoing iron loss.
Review iron-deficiency anemia →The quality and completeness of EGD and colonoscopy are reviewed before moving deeper into the small bowel.
Learn about colonoscopy →Multiple small-bowel angioectasias are identified beyond the reach of routine scopes.
Learn about capsule endoscopy →The most likely bleeding lesions are reached and treated with controlled thermal therapy.
Schedule bleeding review →Management depends on hemodynamic stability, visible versus occult bleeding, lesion location, anemia severity, transfusion need, comorbidities, and whether antithrombotic therapy can be safely adjusted.
Ongoing iron loss after adequate upper and lower endoscopy can justify small-bowel evaluation.
Active visible bleeding may require hospital-level stabilization and urgent endoscopic or radiologic evaluation.
Repeat endoscopy, medical therapy, or a broader search for additional lesions may be needed.
Bleeding control must be balanced against stroke, cardiac, or thrombotic risk.
Associated conditions can increase recurrence and may require coordinated nephrology or cardiology care.
Heavy bleeding, fainting, chest pressure, severe shortness of breath, confusion, or black stool with marked weakness requires urgent assessment.
A visible vascular lesion is clinically important only when it fits the bleeding pattern, anemia, location, and competing diagnoses.
A nonbleeding lesion found in a patient without anemia may not require treatment.
Recurrent iron deficiency can justify treatment even without visible stool blood.
Oozing, adherent clot, or fresh blood increases confidence that the lesion is clinically relevant.
Distributed disease may require a combination of endoscopic, iron, and medical therapy.
Continued transfusion, iron infusion, hospitalization, or repeat-procedure needs can justify medical or multidisciplinary escalation.
The visit connected blood-loss evidence, prior procedure quality, capsule findings, and treatment burden.
Stool color, NSAIDs, antithrombotics, transfusions, iron use, dizziness, and cardiac symptoms were documented.
The team assessed whether repeat EGD or colonoscopy was needed before small-bowel testing.
Obstruction risk, swallowing ability, prior surgery, and the timing of bleeding were considered.
The capsule location helped select the route and target for device-assisted enteroscopy.
Hemoglobin, ferritin, symptoms, transfusions, iron infusions, and hospitalizations became the measures of success.
Treatment combined lesion-directed therapy with restoration of iron and structured recurrence monitoring.
Deep enteroscopy used APC on angioectasias most likely to account for the ongoing blood loss.
Oral or intravenous iron was selected according to severity, tolerance, and response.
Laboratory decline could reveal recurrence before Evelyn saw black or maroon stool.
A new overt bleed, pain, weight loss, or more rapid hemoglobin decline would trigger renewed investigation.
A somatostatin analogue or another specialist-directed option could be considered if transfusion or procedure needs persisted.
These approaches were reserved for active bleeding not controlled or reached endoscopically.
Effective care often connects gastroenterology, capsule interpretation, advanced enteroscopy, hematology, cardiology, nephrology, and medication management.
Upper, lower, and small-bowel findings are considered together.
Lesion timing and location guide the therapeutic route.
Kidney disease, valve disease, heart disease, and antithrombotic needs influence treatment.
The plan tracks blood counts, iron, transfusions, procedures, and symptoms over time.
Complete records help determine whether the bleeding source has already been found, which lesions were treated, and whether small-bowel evaluation is still needed.
Include procedure quality, photographs, pathology, and hemostatic treatment details.
Include lesion location, timing, fresh-blood images, route, and APC or clip treatment.
Provide hemoglobin, ferritin, iron saturation, transfusions, and iron-infusion history.
Include anticoagulants, antiplatelet agents, NSAIDs, supplements, and medicines affecting kidney or heart function.
The procedure offered a treatment opportunity because capsule endoscopy had localized clinically plausible lesions.
Iron replacement alone had not created durable recovery.
No competing upper or colonic source explained the loss.
The lesion distribution allowed a planned therapeutic enteroscopy route.
Evelyn understood that successful APC would not prevent every future lesion.
The appropriate strategy depends on whether lesions are incidental, actively bleeding, recurrent, reachable, or associated with a broader medical condition.
Monitor an incidental lesion or mild stable anemia without immediate endoscopic therapy.
Best for: Nonbleeding lesions or patients whose anemia responds to conservative care
Limitations: Does not control active or clinically significant recurrent bleeding
Takeaway: Treat the patient’s bleeding burden, not the image alone
Use APC, contact thermal therapy, clips, or another method on clinically relevant lesions.
Best for: Reachable angioectasias causing overt bleeding, anemia, or transfusion need
Limitations: Recurrence and procedural injury are possible
Takeaway: Most useful when the lesion matches the bleeding pattern
Use specialist-directed somatostatin analogue or another evidence-based option.
Best for: Multiple, recurrent, difficult-to-reach, or transfusion-dependent angioectasias
Limitations: Side effects, cost, monitoring, and incomplete response
Takeaway: Measure success by reduced bleeding burden over time
Use embolization or surgery in selected uncontrolled active bleeding.
Best for: A localized active source not controlled endoscopically or an unstable patient
Limitations: Ischemia, operative risk, and difficulty treating diffuse disease
Takeaway: Reserve invasive escalation for carefully selected cases
Visible bleeding can underestimate the physiologic impact, particularly in older adults or patients with heart, kidney, or anticoagulation risks.
How diagnosis changed the goal from repeated replacement to measurable bleeding control
Evelyn’s hemoglobin and iron stores improved after enteroscopic treatment and iron replacement.
She resumed walking with less breathlessness and stopped interpreting fatigue as an unavoidable part of aging.
Follow-up focused on laboratory trends rather than waiting for visible bleeding.
She understood that recurrent anemia could come from new angioectasias or a different source and would need reassessment.
The most important change was having a defined pathway for capsule testing, targeted treatment, and escalation if the burden returned.
The diagnosis did not promise that I would never bleed again. It gave us a way to recognize recurrence before I reached another crisis.
This patient journey is an educational composite illustrating one possible course of small-bowel angioectasia bleeding. It does not represent a specific patient. Lesion location, bleeding severity, anemia, comorbidities, anticoagulant decisions, treatment, recurrence, and outcomes vary. Capsule endoscopy is appropriate only after obstruction risk and prior evaluations are considered. Heavy bleeding, fainting, chest pressure, severe shortness of breath, confusion, or black stool with marked weakness requires prompt medical assessment.
Answers about hidden bleeding, anemia, capsule endoscopy, APC, recurrence, medical therapy, anticoagulants, and urgent signs
They are fragile dilated blood vessels in the GI lining that may bleed intermittently.
No. They are vascular lesions, not tumors, although other bleeding causes may need to be excluded.
Yes. Slow occult bleeding can repeatedly lower iron and hemoglobin without obvious stool changes.
The lesions may be in the small bowel or may not be actively bleeding during the procedure.
It is a swallowed camera that records images throughout the small bowel.
Options include iron replacement, endoscopic hemostasis, medical therapy, angiographic embolization, or surgery in selected cases.
Argon plasma coagulation is a noncontact thermal method commonly used to treat superficial vascular lesions.
Yes. Treated sites can recur and new angioectasias can develop.
No. Medication decisions must balance bleeding severity against stroke or thrombotic risk.
Seek urgent care for heavy bleeding, fainting, chest pressure, shortness of breath, confusion, severe weakness, or black stool with dizziness.
Explore related conditions, symptoms, and procedures used during diagnosis and treatment.
Review causes, bleeding patterns, testing, treatment, and recurrence.
Condition Guide →Understand chronic blood loss and iron recovery.
Iron-Deficiency Anemia Guide →Learn how the small-bowel mucosa is visualized.
Capsule Endoscopy Guide →Review black-stool causes and urgent warning signs.
Melena Guide →Arrange review of unexplained anemia, capsule findings, recurrent bleeding, or prior APC.
Book Appointment →Review hemoglobin, ferritin, stool pattern, transfusions, medicines, and competing causes of anemia.
Confirm whether EGD and colonoscopy were complete and whether repeat examination is justified.
Use capsule endoscopy as the first-line small-bowel test in appropriate stable patients.
Use device-assisted enteroscopy or colonoscopic therapy when lesions fit the bleeding pattern.
Integrate iron, medical therapy, comorbidity management, and antithrombotic decisions.
Monitor hemoglobin, iron, transfusions, hospitalizations, overt bleeding, and procedure frequency.
GastroDoxs can review prior scopes, capsule findings, anemia trends, anticoagulants, comorbidities, and the need for endoscopic or medical treatment.